Journal article

Safety of artemisinins in first trimester of prospectively followed pregnancies: an observational study

Kerryn A Moore, Julie A Simpson, Moo Kho Paw, Mupawjay Pimanpanarak, Jacher Wiladphaingern, Marcus J Rijken, Podjanee Jittamala, Nicholas J White, Freya JI Fowkes, Francois Nosten, Rose McGready

LANCET INFECTIOUS DISEASES | ELSEVIER SCI LTD | Published : 2016

Abstract

BACKGROUND: Artemisinins, the most effective antimalarials available, are not recommended for falciparum malaria during the first trimester of pregnancy because of safety concerns. Therefore, quinine is used despite its poor effectiveness. Assessing artemisinin safety requires weighing the risks of malaria and its treatment. We aimed to assess the effect of first-trimester malaria and artemisinin treatment on miscarriage and major congenital malformations. METHODS: In this observational study, we assessed data from antenatal clinics on the Thai-Myanmar border between Jan 1, 1994, and Dec 31, 2013. We included women who presented to antenatal clinics during their first trimester with a viable..

View full abstract